Swiss stocks - Factors to watch on October 17

Reuters

10/17

Swiss stocks - Factors to watch on October 17

ZURICH/GDANSK, Oct 17 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday:

ROCHE HOLDING AG ROG.S

Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price of $50, following similar moves by rivals as they scramble to address pressure from the Trump administration to lower prescription drug prices paid by Americans.

ROCHE HOLDING AG ROG.S

Chinese biotech Hansoh Pharma 3692.HK said on Friday its units have signed a license agreement worth up to $1.45 billion with Roche's subsidiary for an investigational treatment of colorectal cancer and other solid tumors.

ANALYSTS' VIEWS

NESTLE SA NESN.S: Jefferies raises target price to CHF 81 from CHF 77

SANDOZ GROUP AG SDZ.S: Berenberg raises target price to CHF 49 from CHF 41

GALDERMA GROUP AG GALD.S: Berenberg raises target price to CHF 182 from CHF 165

(Reporting by Zurich newsroom and Gdansk newsroom)

((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH  
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2576707022"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2576707022\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2576707022?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 12:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2576707022","market":"us","top_or_hot":-1,"title":"Swiss stocks - Factors to watch on October 17","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Swiss stocks - Factors to watch on October 17</title></head><body><p>\n<span>ZURICH/GDANSK, Oct 17 (Reuters)</span><span> - </span>Here are some of the main factors that may affect Swiss stocks on Friday:</p><p>ROCHE HOLDING AG <span>ROG.S</span> </p><p>Roche on Thursday <span>launched</span> direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price of $50, following similar moves by rivals as they scramble to address pressure from the Trump administration to lower prescription drug prices paid by Americans.</p><p>ROCHE HOLDING AG <span>ROG.S</span> </p><p>Chinese biotech Hansoh Pharma <span>3692.HK</span> said on Friday its units have signed a <span>license agreement</span> worth up to $1.45 billion with Roche's subsidiary for an investigational treatment of colorectal cancer and other solid tumors.</p><p>ANALYSTS' VIEWS</p><p>NESTLE SA <span>NESN.S</span>: Jefferies raises target price to CHF 81 from CHF 77</p><p>SANDOZ GROUP AG <span>SDZ.S</span>: Berenberg raises target price to CHF 49 from CHF 41</p><p><a href=\"https://laohu8.com/S/GALDY\">GALDERMA GROUP AG</a> <span>GALD.S</span>: Berenberg raises target price to CHF 182 from CHF 165</p><p> (Reporting by Zurich newsroom and Gdansk newsroom)</p><p> ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))</p><div><pre>For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g<br/><br/>FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:<br/>Daily Swiss stock market report in German <span>.SDE</span><br/>All SMI constituent stocks <span>0#.SSMI</span><br/>DJ STOXX index <span>.STOXX</span><br/>Top 10 STOXX sectors <span>.PGL.STOXXS</span><br/>Top 10 EUROSTOXX sectors <span>.PGL.STOXXES</span><br/><br/>Swiss mid-cap index <span>.SSMI</span><br/>Swiss all-share index <span>.SSHI</span><br/>Swiss market digest <span>.AD.S</span><br/>Sector overview <span>CH/SECTOR1</span><br/>All Swiss news <span>CH</span><br/>Swiss research news <span>CH-RCH</span>  <br/>All equity news <span>E</span><br/><br/>SPEED GUIDES:  <span>EQUITY</span>, <span>EQUITY/NEWS1</span>, <span>EUR/EQUITY</span>, <span>SWITZERLAND</span>, <span>REUTERS</span> \n</pre></div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Swiss stocks - Factors to watch on October 17</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSwiss stocks - Factors to watch on October 17\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-17 12:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Swiss stocks - Factors to watch on October 17</title></head><body><p>\n<span>ZURICH/GDANSK, Oct 17 (Reuters)</span><span> - </span>Here are some of the main factors that may affect Swiss stocks on Friday:</p><p>ROCHE HOLDING AG <span>ROG.S</span> </p><p>Roche on Thursday <span>launched</span> direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price of $50, following similar moves by rivals as they scramble to address pressure from the Trump administration to lower prescription drug prices paid by Americans.</p><p>ROCHE HOLDING AG <span>ROG.S</span> </p><p>Chinese biotech Hansoh Pharma <span>3692.HK</span> said on Friday its units have signed a <span>license agreement</span> worth up to $1.45 billion with Roche's subsidiary for an investigational treatment of colorectal cancer and other solid tumors.</p><p>ANALYSTS' VIEWS</p><p>NESTLE SA <span>NESN.S</span>: Jefferies raises target price to CHF 81 from CHF 77</p><p>SANDOZ GROUP AG <span>SDZ.S</span>: Berenberg raises target price to CHF 49 from CHF 41</p><p><a href=\"https://laohu8.com/S/GALDY\">GALDERMA GROUP AG</a> <span>GALD.S</span>: Berenberg raises target price to CHF 182 from CHF 165</p><p> (Reporting by Zurich newsroom and Gdansk newsroom)</p><p> ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))</p><div><pre>For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g<br/><br/>FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:<br/>Daily Swiss stock market report in German <span>.SDE</span><br/>All SMI constituent stocks <span>0#.SSMI</span><br/>DJ STOXX index <span>.STOXX</span><br/>Top 10 STOXX sectors <span>.PGL.STOXXS</span><br/>Top 10 EUROSTOXX sectors <span>.PGL.STOXXES</span><br/><br/>Swiss mid-cap index <span>.SSMI</span><br/>Swiss all-share index <span>.SSHI</span><br/>Swiss market digest <span>.AD.S</span><br/>Sector overview <span>CH/SECTOR1</span><br/>All Swiss news <span>CH</span><br/>Swiss research news <span>CH-RCH</span>  <br/>All equity news <span>E</span><br/><br/>SPEED GUIDES:  <span>EQUITY</span>, <span>EQUITY/NEWS1</span>, <span>EUR/EQUITY</span>, <span>SWITZERLAND</span>, <span>REUTERS</span> \n</pre></div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL5N3VY02B:1","article_id":"2576707022","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2576707022","pubTimestamp":1760677123,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Swiss stocks - Factors to watch on October 17 ZURICH/GDANSK, Oct 17 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday:ROCHE HOLDING AG ROG.S Roche on Thursday launch","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","03692":"翰森制药","BK1589":"北水核心资产","BK1191":"制药"},"translate_title":"瑞士股市-10月17日值得关注的因素","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":0.9},"content_text":"Swiss stocks - Factors to watch on October 17\nZURICH/GDANSK, Oct 17 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Friday:ROCHE HOLDING AG ROG.S Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price of $50, following similar moves by rivals as they scramble to address pressure from the Trump administration to lower prescription drug prices paid by Americans.ROCHE HOLDING AG ROG.S Chinese biotech Hansoh Pharma 3692.HK said on Friday its units have signed a license agreement worth up to $1.45 billion with Roche's subsidiary for an investigational treatment of colorectal cancer and other solid tumors.ANALYSTS' VIEWSNESTLE SA NESN.S: Jefferies raises target price to CHF 81 from CHF 77SANDOZ GROUP AG SDZ.S: Berenberg raises target price to CHF 49 from CHF 41GALDERMA GROUP AG GALD.S: Berenberg raises target price to CHF 182 from CHF 165 (Reporting by Zurich newsroom and Gdansk newsroom) ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6gFOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:Daily Swiss stock market report in German .SDEAll SMI constituent stocks 0#.SSMIDJ STOXX index .STOXXTop 10 STOXX sectors .PGL.STOXXSTop 10 EUROSTOXX sectors .PGL.STOXXESSwiss mid-cap index .SSMISwiss all-share index .SSHISwiss market digest .AD.SSector overview CH/SECTOR1All Swiss news CHSwiss research news CH-RCH  All equity news ESPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}